Repression of tumor survival pathways by novel and selective inhibitors of MNK1 and MNK2 kinases in glioblastoma and colorectal cancer

被引：0

作者：

Rzymski, Tomasz ^{[1
]}

Szajewska-Skuta, Malgorzata ^{[1
]}

Zarebski, Adrian ^{[1
]}

Sitarz, Kamil ^{[1
]}

Sapala, Lukasz ^{[1
]}

Zurawska, Malgorzata ^{[1
]}

Salwinska, Magdalena ^{[1
]}

Windak, Renata ^{[1
]}

Trebacz, Ewa ^{[1
]}

Daniel-Wojcik, Joanna ^{[1
]}

Obuchowicz, Radoslaw ^{[1
]}

Winnik, Bozena ^{[1
]}

Wincza, Ewelina ^{[1
]}

Kulesza, Urszula ^{[1
]}

Kucwaj-Borysz, Katarzyna ^{[1
]}

Milik, Mariusz ^{[1
]}

Dreas, Agnieszka ^{[1
]}

Brzozka, Krzysztof ^{[1
]}

机构：

[1] Selvita SA, Krakow, Poland

来源：

CANCER RESEARCH | 2014年 / 74卷 / 19期

关键词：

D O I：

10.1158/1538-7445.AM2014-755

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

755

引用

页数：1

共 50 条

[1] Repression of tumor survival pathways by novel, selective inhibitors of MNK1 and MNK2 kinases
Rzymski, Tomasz
Dreas, Agnieszka
Milik, Mariusz
Kucwaj, Katarzyna
Zarebski, Adrian
Skuta, Malgorzata Szajewska
Cierpich, Anna
Fabritius, Charles
Brzozka, Krzysztof
CANCER RESEARCH, 2013, 73
[2] Mitogen-activated protein kinases activate the serine/threonine kinases Mnk1 and Mnk2
Waskiewicz, AJ
Flynn, A
Proud, CG
Cooper, JA
EMBO JOURNAL, 1997, 16 (08): : 1909 - 1920
[3] Mitogen-activated Protein Kinase (MAPK) Interacting Kinases 1 and 2 (MNK1 and MNK2) as Targets for Cancer Therapy: Recent Progress in the Development of MNK Inhibitors
Dreas, Agnieszka
Mikulski, Maciej
Milik, Mariusz
Fabritius, Charles-Henry
Brzozka, Krzysztof
Rzymski, Tomasz
CURRENT MEDICINAL CHEMISTRY, 2017, 24 (28) : 3025 - 3053
[4] MNK1 and MNK2 regulation in HER2-overexpressing breast cancer lines
Chrestensen, Carol A.
Shuman, Jacquelyn K.
Eschenroeder, Andrew
Worthington, Mark
Gram, Hermann
Sturgil, Thomas W.
JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (07) : 4243 - 4252
[5] MNK1 and MNK2 Expression in the Human Dorsal Root and Trigeminal Ganglion
Shiers, Stephanie
Sahn, James J.
Price, Theodore J.
NEUROSCIENCE, 2023, 515 : 96 - 107
[6] Identification of a Highly Conserved Allosteric Binding Site on Mnk1 and Mnk2
Basnet, Sunita K. C.
Diab, Sarah
Schmid, Raffaella
Yu, Mingfeng
Yang, Yuchao
Gillam, Todd Alexander
Teo, Theodosia
Li, Peng
Peat, Tom
Albrecht, Hugo
Wang, Shudong
MOLECULAR PHARMACOLOGY, 2015, 88 (05) : 935 - 948
[7] Design, synthesis and activity of Mnk1 and Mnk2 selective inhibitors containing thieno[2,3-d]pyrimidine scaffold
Jin, Xin
Merrett, James
Tong, Sheng
Flower, Bartholomew
Xie, Jianling
Yu, Rilei
Tian, Shuye
Gao, Ling
Zhao, Jiajun
Wang, Xuemin
Jiang, Tao
Proud, Christopher G.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 162 : 735 - 751
[8] Regulation of arsenic trioxide-induced cellular responses by Mnk1 and Mnk2
Dolniak, Blazej
Katsoulidis, Efstratios
Carayol, Nathalie
Altman, Jessica K.
Redig, Amanda J.
Tallman, Martin S.
Ueda, Takeshi
Watanabe-Fukunaga, Rie
Fukunaga, Rikiro
Platanias, Leonidas C.
JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (18) : 12034 - 12042
[9] Combined deficiency for MAP kinase-interacting kinase 1 and 2 (Mnk1 and Mnk2) delays tumor development
Ueda, Takeshi
Sasaki, Masato
Elia, Andrew J.
Chio, Iok In Christine
Hamada, Koichi
Fukunaga, Rikiro
Mak, Tak W.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (32) : 13984 - 13990
[10] eFT508, a potent and highly selective inhibitor of MNK1 and MNK2, is an activator of anti-tumor immune response
Webster, Kevin
Sharma, Rajesh
Goel, Vikas
Stumpf, Craig
Stauton, Jocelyn
Thompson, Peggy
Chiang, Gary
Xu, Yichen
Jin, Hyun Yong
Ruggero, Davide
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5

← 1 2 3 4 5 →